---
title: "CDNA: Q2 2026 revenue rose 52% to $132M, net income hit $111M, boosted by a major asset sale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294409644.md"
description: "Revenue surged 52% year-over-year to $132 million in Q2 2026, with net income of $111 million driven by a $113 million gain from the lab products business sale. Testing services and digital solutions saw robust growth, and the company completed the acquisition of Naveris while maintaining a strong cash position.Original document: CareDx, Inc. [CDNA] SEC 10-Q Quarterly Report — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T20:13:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294409644.md)
  - [en](https://longbridge.com/en/news/294409644.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294409644.md)
---

# CDNA: Q2 2026 revenue rose 52% to $132M, net income hit $111M, boosted by a major asset sale

Revenue surged 52% year-over-year to $132 million in Q2 2026, with net income of $111 million driven by a $113 million gain from the lab products business sale. Testing services and digital solutions saw robust growth, and the company completed the acquisition of Naveris while maintaining a strong cash position.

Original document: CareDx, Inc. \[CDNA\] SEC 10-Q Quarterly Report — Jul. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CDNA.US](https://longbridge.com/en/quote/CDNA.US.md)

## Related News & Research

- [CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News](https://longbridge.com/en/news/294561699.md)
- [CareDx Q2 revenue beats estimates; outlook lifted](https://longbridge.com/en/news/294409121.md)
- [OSK: Q2 2026 sales rose 6.7% but margins declined; 2026 EPS guidance was revised lower](https://longbridge.com/en/news/294100394.md)
- [EXPO: Double-digit growth in Q2 2026, raised 2026 guidance, and strong AI-driven demand](https://longbridge.com/en/news/294421668.md)
- [BEI.UN: Stable Q2 2026 results, strong capital allocation, and reaffirmed 2026 guidance](https://longbridge.com/en/news/294117949.md)